Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	OCP + Placebo	79
Overall Study	STARTED	Metformin + Placebo	81
Overall Study	STARTED	OCP + Metformin	80
Overall Study	End of study outcome	OCP + Placebo	59
Overall Study	End of study outcome	Metformin + Placebo	65
Overall Study	End of study outcome	OCP + Metformin	63
Overall Study	COMPLETED	OCP + Placebo	52
Overall Study	COMPLETED	Metformin + Placebo	60
Overall Study	COMPLETED	OCP + Metformin	57
Overall Study	NOT COMPLETED	OCP + Placebo	27
Overall Study	NOT COMPLETED	Metformin + Placebo	21
Overall Study	NOT COMPLETED	OCP + Metformin	23

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03229057/flow